Organogenesis Holdings Inc. Announces Management Change


CANTON, Mass., Aug. 24, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced the resignation of Chief Financial Officer Timothy M. Cunningham effective August 18, 2020. Mr. Cunningham's resignation is not the result of any dispute or disagreement with Organogenesis or any matter relating to the Company's accounting practices or financial statements. Henry Hagopian, the Company's Vice President of Finance and Treasurer has assumed the role of interim Chief Financial Officer in addition to his current responsibilities. The Company has …

Full story available on


Please enter your comment!
Please enter your name here